DK0827537T3 - Chromatin-regulator-gener - Google Patents

Chromatin-regulator-gener

Info

Publication number
DK0827537T3
DK0827537T3 DK96914165T DK96914165T DK0827537T3 DK 0827537 T3 DK0827537 T3 DK 0827537T3 DK 96914165 T DK96914165 T DK 96914165T DK 96914165 T DK96914165 T DK 96914165T DK 0827537 T3 DK0827537 T3 DK 0827537T3
Authority
DK
Denmark
Prior art keywords
regulator genes
chromatin regulator
genes
chromatin
deregulation
Prior art date
Application number
DK96914165T
Other languages
English (en)
Inventor
Thomas Jenuwein
Goetz Laible
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0827537T3 publication Critical patent/DK0827537T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96914165T 1995-05-10 1996-05-02 Chromatin-regulator-gener DK0827537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19516776A DE19516776A1 (de) 1995-05-10 1995-05-10 Chromatin-Regulatorgene
PCT/EP1996/001818 WO1996035784A2 (de) 1995-05-10 1996-05-02 Chromatin-regulatorgene

Publications (1)

Publication Number Publication Date
DK0827537T3 true DK0827537T3 (da) 2008-12-01

Family

ID=7761318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96914165T DK0827537T3 (da) 1995-05-10 1996-05-02 Chromatin-regulator-gener

Country Status (11)

Country Link
US (2) US6689583B1 (da)
EP (1) EP0827537B1 (da)
JP (1) JP4295824B2 (da)
AT (1) ATE404667T1 (da)
CA (1) CA2220442C (da)
DE (2) DE19516776A1 (da)
DK (1) DK0827537T3 (da)
ES (1) ES2313726T3 (da)
MX (1) MX9708401A (da)
PT (1) PT827537E (da)
WO (1) WO1996035784A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
US6239327B1 (en) 1998-04-16 2001-05-29 Cold Spring Harbor Laboratory Seed specific polycomb group gene and methods of use for same
ATE441717T1 (de) 1999-03-11 2009-09-15 Arborgen Llc Zusammensetzungen und verfahren zur veränderung der gentranskription
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
US6555329B2 (en) * 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020155460A1 (en) * 2000-10-10 2002-10-24 Genencor International Inc. Information rich libraries
US7264964B2 (en) 2001-06-22 2007-09-04 Ceres, Inc. Chimeric histone acetyltransferase polypeptides
US20040053848A1 (en) * 2001-08-23 2004-03-18 Allis C. David Antibodies specific for methylated lysines in histones
CA2471385A1 (en) * 2001-12-27 2003-07-10 Takeda Chemical Industries, Ltd. Preventives/remedies for cancer
GB0228900D0 (en) * 2002-12-11 2003-01-15 Ml Lab Plc Cancer Immunotherapy
US20060104981A1 (en) * 2002-12-24 2006-05-18 Yuichi Hikichi Prophylactic/therapeutic agent for cancer
CA2548185A1 (en) 2003-12-03 2005-06-16 Chugai Seiyaku Kabushiki Kaisha Expression systems using mammalian .beta.-actin promoter
JP2005170799A (ja) * 2003-12-08 2005-06-30 Univ Kurume ｚｅｓｔｅホモログ２のエンハンサーのＨＬＡ−Ａ２４結合ペプチド
DE602005017781D1 (de) * 2004-06-01 2009-12-31 Univ North Carolina Rekonstituierter histon-methyltransferase-komplex und verfahren zur identifizierung von modulatoren dafür
JP2009528050A (ja) * 2006-02-27 2009-08-06 イムジェン カンパニー リミテッド Ｂｍｉ−１を用いた星状細胞の神経幹細胞への脱分化
US8574832B2 (en) 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
WO2011160206A1 (en) 2010-06-23 2011-12-29 Morin Ryan D Biomarkers for non-hodgkin lymphomas and uses thereof
US20130195843A1 (en) * 2010-06-23 2013-08-01 British Columbia Cancer Agency Branch Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
US9175331B2 (en) 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
HUE028977T2 (en) * 2010-09-10 2017-02-28 Epizyme Inc A method for determining the suitability of human EZH2 inhibitors during treatment
WO2012050963A2 (en) 2010-09-29 2012-04-19 The General Hospital Corporation D/B/A Massachusetts General Hospital Agents providing controls and standards for immuno-precipitation assays
TWI598336B (zh) 2011-04-13 2017-09-11 雅酶股份有限公司 經取代之苯化合物
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
DK3628670T3 (da) 2012-04-13 2022-12-05 Epizyme Inc Saltform til ezh2-hæmning
CN110041250A (zh) 2012-10-15 2019-07-23 Epizyme股份有限公司 经取代的苯化合物
EP2968565A2 (en) 2013-03-14 2016-01-20 Genentech, Inc. Methods of treating cancer and preventing cancer drug resistance
CN103215352B (zh) * 2013-03-29 2015-03-11 中国医学科学院血液病医院（血液学研究所） 一种检测setd2基因突变的试剂盒
MX2016004703A (es) 2013-10-16 2017-02-28 Epizyme Inc Forma salina de hidrocloruro para la inhibicion de ezh2.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486623A (en) 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
WO1998027994A1 (en) 1996-12-20 1998-07-02 Board Of Regents, The University Of Texas System Proteins and compositions for modulating mitosis
US6004933A (en) 1997-04-25 1999-12-21 Cortech Inc. Cysteine protease inhibitors
US5972608A (en) * 1997-08-27 1999-10-26 University Of Massachusetts Assays and reagents for chromatin remodeling enzymes and their modulators
EP1029547A1 (en) 1999-02-15 2000-08-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Pharmaceutically active compounds and method for identifying same
US20020039776A1 (en) * 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them
US6555329B2 (en) * 2000-06-09 2003-04-29 Boehringer Ingelheim International Gmbh Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
US20020164620A1 (en) * 2001-01-19 2002-11-07 Boehringer Ingelheim International Gmbh Method for identifying compounds modulating sister chromatid separation
EP1227160A1 (en) 2001-01-19 2002-07-31 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Compounds modulating sister chromatid separation and method for identifying same
CN1678735A (zh) * 2001-05-04 2005-10-05 佛罗里达大学研究基金会有限公司 来源于细菌的丙酮酸脱羧酶(pdc)基因的克隆和测序及其用途

Also Published As

Publication number Publication date
CA2220442C (en) 2011-07-12
ATE404667T1 (de) 2008-08-15
DE19516776A1 (de) 1996-11-14
CA2220442A1 (en) 1996-11-14
PT827537E (pt) 2008-10-09
WO1996035784A2 (de) 1996-11-14
DE59611481D1 (en) 2008-09-25
US7252968B2 (en) 2007-08-07
EP0827537B1 (de) 2008-08-13
WO1996035784A3 (de) 1996-12-27
JP2001505402A (ja) 2001-04-24
MX9708401A (es) 1998-02-28
US20050089880A1 (en) 2005-04-28
EP0827537A2 (de) 1998-03-11
US6689583B1 (en) 2004-02-10
ES2313726T3 (es) 2009-03-01
JP4295824B2 (ja) 2009-07-15

Similar Documents

Publication Publication Date Title
DK0827537T3 (da) Chromatin-regulator-gener
ES2182906T3 (es) Grapa quirurgica helicoidal.
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
ATE301457T1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
TR199701056T1 (xx) Farnesil-protein transferaz enzimi inhibit�rleri.
BR9805544A (pt) Uso de um composto.
EP0840608A4 (en) TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
DE69905170T2 (de) Thiazolopyrimidinderivate
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
PT1149092E (pt) 4- e 5-alciniloxindois e 4- e 5-alceniloxindois
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
PT815087E (pt) Derivados de fenilo trissubstituidos
DE60037813D1 (de) Antworten auf hypoxia modifizieren
TR199802704T2 (xx) H�V tedavisinde Vx478, Zidov�din, FTC ve/veya 3TC i�eren kombinasyonlar�n kullan�m�.
NO981019D0 (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
AU1278600A (en) Novel therapeutic application of nicergoline
NO20005548D0 (no) Mykobakterieinhibitorer
DE59409704D1 (de) In den menschlichen körper einführbares instrument
HUP9802842A2 (hu) Fungicid keverékek
DE69838686D1 (de) Tripeptidylpeptidaseinhibitoren
TR199802703T2 (xx) HIV tedavisinde Vx478, Zidov�din, ve/veya 1592U89 i�eren kombinasyonlar�n kullan�m�.